The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 19, 2025 for Tenshi Pharmaceuticals Pvt Ltd
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma's promoter Tenshi Pharmaceuticals Pvt Ltd has created a pledge on 20,00,000 equity shares (1.75% of total share capital) on December 16, 2025. The pledge was taken for a loan against shares to meet certain business and operational needs, with Catalyst Trusteeship Limited named as the entity holding the encumbered shares. After this pledge, Tenshi's encumbered shares rise to 86,51,274 (7.55% of share capital), and the total promoter group encumbrance stands at 94,37,176 shares (8.24% of share capital). The overall promoter group holding in Onesource Specialty Pharma is 3,42,96,199 shares, representing 17.91% of the company's share capital.
This is a routine disclosure of a new promoter share pledge against a loan, not a change in ownership. It signals that the promoter is leveraging its stake for funding, which adds a layer of risk if the loan is not repaid; however, the promoter group's overall stake of 17.91% remains well below the 50% threshold.